Janux Therapeutics, Inc. (JANX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$157.67M | -59.5% |
| 2024 | -$98.85M | -35.4% |
| 2023 | -$72.98M | -8.8% |
| 2022 | -$67.09M | -103.7% |
| 2021 | -$32.93M | -579.9% |
| 2020 | -$4.84M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$157.67M | -59.5% |
| 2024 | -$98.85M | -35.4% |
| 2023 | -$72.98M | -8.8% |
| 2022 | -$67.09M | -103.7% |
| 2021 | -$32.93M | -579.9% |
| 2020 | -$4.84M | — |